Table 2.
Immunosuppression at BNR onset.
Immunosuppression at BNR | BNR cases (N = 12) |
---|---|
Cyclosporine (%) | 5/12 (42%) |
Dose (mg ± SD) | 194 ± 13 |
Trough level (ng/mL ± SD) | 227 ± 66 |
Reason for switching from tacrolimus | Tacrolimus reduces seizure threshold |
Tacrolimus (%) | 6/12 (50%) |
Dose (mg ± SD) | 5.3 ± 1.8 |
Trough level (ng/mL ± SD) | 10.0 ± 4.6 |
Sirolimus (%) | 1/12 (8%) |
Reason for switching from tacrolimus | Renal insufficiency |
Azathioprine (%) | 1/12 (8%) |
Mycophenolate mofetil (%) | 11/12 (92%) |
Dose (mg ± SD) | 1889 ± 821 |
Trough level (μg/ML) | 2.0 ± 1.6 |